Reservoir targeted vaccine against borrelia burgdorferi: A new strategy to prevent lyme disease transmission

Journal of Infectious Diseases

Volumn 209, Issue 12, 2014, Pages 1972-1980

  Richer, Luciana Meirelles ^a,b,f   Brisson, Dustin ^c   Melo, Rita ^a   Ostfeld, Richard S ^d   Zeidner, Nordin ^e   Gomes Solecki, Maria ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Biopeptides Corp   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CARY INSTITUTE OF ECOSYSTEM STUDIES   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Borrelia burgdorferi; enzootic cycle; Lyme disease; Oral vaccine; transmission; wildlife reservoir

Indexed keywords

OUTER SURFACE PROTEIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTHROPOD LIFE CYCLE STAGE; ARTICLE; BACTERIAL TRANSMISSION; BORRELIA BURGDORFERI; CONTROLLED STUDY; INFECTION PREVENTION; INFECTION RISK; IXODES SCAPULARIS; LIFE CYCLE STAGE; LYME DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK REDUCTION; SEROPREVALENCE; VACCINATION;

BORRELIA BURGDORFERI; ENZOOTIC CYCLE; LYME DISEASE; ORAL VACCINE; TRANSMISSION; WILDLIFE RESERVOIR;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; DISEASE RESERVOIRS; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; MICE; PEROMYSCUS; TICKS; VACCINATION;

EID: 84901757308     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu005     Document Type: Article

References (33)

1. Kurtenbach K, Hanincova K, Tsao JI, Margos G, Fish D, Ogden NH. Fundamental processes in the evolutionary ecology of Lyme borreliosis. Nat Rev Microbiol 2006; 4:660-9.
2. Dolan MC, Maupin GO, Schneider BS, et al. Control of immature Ixodes scapularis (Acari: Ixodidae) on rodent reservoirs of Borrelia burgdorferi in a residential community of southeastern Connecticut. J Med Entomol 2004; 41:1043-54. (Pubitemid 39606427)
3. Scheckelhoff MR, Telford SR, Hu LT. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs. Vaccine 2006; 24:1949-57. (Pubitemid 43238278)
4. Tsao JI, Wootton JT, Bunikis J, Luna MG, Fish D, Barbour AG. An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc Natl Acad Sci U S A 2004; 101:18159-64. (Pubitemid 40054090)
5. Gomes-Solecki MJ, Brisson DR, Dattwyler RJ. Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait. Vaccine 2006; 24:4440-9.
6. Hoen AG, Rollend LG, Papero MA, et al. Effects of tick control by acaricide self-treatment of white-tailed deer on host-seeking tick infection prevalence and entomologic risk for Ixodes scapularis-borne pathogens. Vector Borne Zoonotic Dis 2009; 9:431-8.
7. Patrican LA. Absence of Lyme disease spirochetes in larval progeny of naturally infected Ixodes scapularis (Acari:Ixodidae) fed on dogs. J Med Entomol 1997; 34:52-5. (Pubitemid 127460902)
8. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 1998; 339:209-15. (Pubitemid 28350162)
9. Chang YF, Appel MJ, Jacobson RH, et al. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi. Infect Immun 1995; 63:3543-9.
10. Fikrig E, Barthold SW, Kantor FS, Flavell RA. Long-term protection of mice from Lyme disease by vaccination with OspA. Infect Immun 1992; 60:773-7.
11. Tsao J, Barbour AG, Luke CJ, Fikrig E, Fish D. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks. Vector Borne Zoonotic Dis 2001; 1:65-74.
12. Fikrig E, Barthold SW, Kantor FS, Flavell RA. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J Infect Dis 1991; 164:1224-7.
13. Ostfeld RS, Canham CD, Oggenfuss K, Winchcombe RJ, Keesing F. Climate, deer, rodents, and acorns as determinants of variation in lymedisease risk. PLoS Biol 2006; 4:e145.
14. Meirelles Richer L, Aroso M, Contente-Cuomo T, Ivanova L, Gomes-Solecki M. Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice. Clin Vaccine Immunol 2011; 18:1809-16.
15. Crowder CD, Matthews HE, Schutzer S, et al. Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe. PLoS One 2010; 5:e10650.
16. Hodzic E, Feng S, Freet KJ, Borjesson DL, Barthold SW. Borrelia burgdorferi population kinetics and selected gene expression at the hostvector interface. Infect Immun 2002; 70:3382-8. (Pubitemid 34665973)
17. R Development CoreTeam. R: A language and environment for statistical computing. Vienna, Austria: Foundation for Statistical Computing, 2012. http://www.R-project.org. Accessed 10 September 2013.
18. LoGiudice K, Ostfeld RS, Schmidt KA, Keesing F. The ecology of infectious disease: effects of host diversity and community composition on Lyme disease risk. Proc Natl Acad Sci U S A 2003; 100:567-71. (Pubitemid 36126092)
19. Bunikis J, Tsao J, Luke CJ, Luna MG, Fish D, Barbour AG. Borrelia burgdorferi infection in a natural population of Peromyscus Leucopus mice: a longitudinal study in an area where Lyme Borreliosis is highly endemic. J Infect Dis 2004; 189:1515-23. (Pubitemid 38543601)
20. Telford SR III, Cunningham JA, Waltari E, Hu L. Nest box-deployed bait for delivering oral vaccines to white-footed mice. Ticks Tick Borne Dis 2011; 2:151-5.
21. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A 1995; 92:2909-13.
22. de Silva AM, Telford SR III, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 1996; 183:271-5. (Pubitemid 26028766)
23. Kalish RA, Leong JM, Steere AC. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993; 61:2774-9. (Pubitemid 23182268)
24. Boutin S. Food supplementation experiments with terrestrial vertebrates patterns, problems, and the future. Can J Zool 1990; 68:203-20. (Pubitemid 20428186)
25. Gilbert BS, Krebs CJ. Effects of extra food on Peromyscus and Clethrionomys populations in the southern Yukon. Oecologia 1981; 51:326-31.
26. Diuk-Wasser MA, Hoen AG, Cislo P, et al. Human risk of infection with Borrelia burgdorferi, the Lyme disease agent, in eastern United States. Am J Trop Med Hyg 2012; 86:320-7.
27. Stafford KC III, Cartter ML, Magnarelli LA, Ertel SH, Mshar PA. Temporal correlations between tick abundance and prevalence of ticks infected with Borrelia burgdorferi and increasing incidence of Lyme disease. J Clin Microbiol 1998; 36:1240-4. (Pubitemid 28208006)
28. Ostfeld RS. Lyme disease: the ecology of a complex system, 1st ed. New York: Oxford University Press, 2011:216.
29. Clark RP, Hu LT. Prevention of Lyme disease and other tick-borne infections. Infect Dis Clin North Am 2008; 22:381-96, vii.
30. Voordouw MJ, Tupper H, Onder O, et al. Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission. Vector Borne Zoonotic Dis 2013; 13:203-14.
31. Ginsberg HS. Transmission risk of Lyme disease and implications for tick management. Am J Epidemiol 1993; 138:65-73.
32. Brisson D, Dykhuizen DE, Ostfeld RS. Conspicuous impacts of inconspicuous hosts on the Lyme disease epidemic. Proc Biol Sci 2008; 275:227-35. (Pubitemid 350174590)
33. Young JD. Underreporting of Lyme disease. N Engl J Med 1998; 338:1629.